Strut Health Tirzepatide Review: Injection, Oral & Terms

Strut Health’s named injection page advertises $219 for a monthly vial of compounded tirzepatide, while its oral page advertises $199 for a thirty-day supply of compounded buccal lozenges. Provider consultations and shipping are included in both published offers. The routes differ in formulation and evidence; the lower oral price does not establish equivalent absorption or outcomes.^5,6

The injection page identifies tirzepatide with vitamin B6. The oral product is a daily buccal lozenge, described as dissolving between cheek and gum, rather than the FDA-approved injected preparation. Neither compounded product is FDA-approved.^5,6

Price, supply and recurring billing

The injection’s pricing section labels $219 as a monthly vial and monthly supply; its hero uses “as low as” and an auto-refill label. The oral pricing section specifies thirty days at $199 and calls it a subscription. Both pages reserve final pricing to the completed consultation. Confirm the selected formulation, prescribed quantity and next charge before authorizing the recurring plan.^5,6

Section 20 of the Terms says prescriptions are subscriptions, with the full prescription amount charged every thirty or ninety days according to the refill schedule until paused or canceled. The product’s monthly description therefore does not establish a calendar-month charge date or the schedule of every available refill plan.⁷

Both products advertise flat-rate pricing, free provider visits, follow-ups, messaging and discreet shipping. Those statements describe the service offer; they do not establish an independently tested response time or guarantee unlimited live visits. Ask how clinical questions are handled and whether video care is appropriate or required in your case.

Medical necessity and oral evidence

The current product pages require a clinician to determine that a compounded formulation is medically necessary and appropriate. Completing an online questionnaire does not guarantee a prescription. A preference for avoiding injections is a question for the clinician, not evidence that the oral route is interchangeable with an approved injection.^5,6

Oral tirzepatide also has a separate evidence problem. Clinical studies of branded injectable medication do not establish equal absorption, dosing or outcomes for a compounded lozenge. Our oral tirzepatide guide discusses why the route matters. We would not choose the oral product solely by comparing its price with the injection's.

Which organization provides treatment?

Strut Health, LLC’s Terms distinguish its nonclinical platform from medical care through Titan Health, P.A. and affiliated entities, also described as Titan Medical Group. The telemedicine consent repeats that clinical relationship. It describes asynchronous review and synchronous video as available forms of telehealth without promising one format for every patient.^7,8

The consent separately identifies Junction and OpenLoop for laboratory services. That lab-specific language should not be treated as proof that OpenLoop supplies the tirzepatide prescribing service. The named product pages say prescriptions are filled by U.S. pharmacies but do not identify an assigned dispenser. Confirm the actual pharmacy and the prescription-label directions before using medication.⁸

Cancellation is not a medication refund

The Terms permit pausing or canceling by emailing Strut’s care team. The product pages’ “cancel anytime” wording does not reverse every already-authorized order. The published refund policy, last modified September 21, 2021, denies cancellation refunds after pharmacy processing and says medications that leave the pharmacy cannot be returned or refunded.^3,7

No specific advance-day cutoff is supplied in those provisions. Ask when the next refill will enter pharmacy processing and save the cancellation confirmation. Waiting until shipment or delivery may be too late under the written policy. The general Terms also say placing an order does not ensure acceptance and permit cancellation of an unshippable order after thirty days; that is not an unconditional clinical-denial refund promise.⁷

For defective or damaged items, the refund policy describes replacement and requires contact within two weeks of delivery. Keep the packaging and order details, and ask the dispensing pharmacy about medication-integrity concerns. A general final-sale clause does not establish whether a specific damaged shipment will be replaced without review.³

FDA warning letter: what it concerns

FDA issued a warning letter in February 2026 to Strut Health, LLC dba Strut, MARCS-CMS 721448. The letter is dated February 20 and identifies struthealth.com. It concerns false or misleading compounded-drug marketing, including pictured labeling that implied Strut itself compounded products and claims that could imply FDA evaluation or approval.⁴

The letter addresses the website reviewed by the agency at that time. It does not establish a current recall, closure or the status of the company's response. We retain the original FDA link so readers can assess the agency's concerns directly without assuming that an older marketing finding proves the quality of every current prescription.

Comparing the offers

Strut publishes distinct injection and oral prices with ongoing care advertised as included. The important trade-offs are the compounded formulation, clinical eligibility, recurring prescription schedule and pharmacy-processing refund cutoff. We have not used the service or independently inspected its pharmacy operations.

For an injection-focused price comparison, consider MadeMed and Actin, accounting for their different commitments. For FDA-approved Zepbound, compare Ro and our brand cost guide.